Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
Press releases published on June 23, 2025

Cellulite Treatment Market Analysis 2025 – Insights for Long-Term Investment & Planning
The Business Research Company’s Cellulite Treatment Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report …

Next Generation Sequencing (NGS) Market Growth | Trends, Opportunities & Forecast 2025 | DataM Intelligence
The Next Generation Sequencing (NGS) Market is expected to reach at a CAGR of 11.6% during the forecast period 2025-2033. AUSTIN, TX, UNITED STATES, June 23, 2025 /EINPresswire.com/ -- The Next Generation Sequencing (NGS) Market is projected to increase …

Key Trend Shaping The Mycobacterium Tuberculosis Market In 2025: Advancements In Automated Tuberculosis Testing
The Business Research Company's Mycobacterium Tuberculosis Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest …

Peripheral IV Catheters Market Report 2025 – For Strategy Officers And Market Intelligence Teams
The Business Research Company's Peripheral IV Catheters Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /EINPresswire.com/ -- The peripheral IV catheters market size …

Global MSI-H And DMMR Market Forecast To Reach $17.40 Billion By 2029 With 23.1% Annual Growth
The Business Research Company's MSI-H And dMMR Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report …

Global Skin Microbiome Market To Reach $1.54 Billion By 2029 With A Growth Rate Of 13.1%
The Business Research Company's Skin Microbiome Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /EINPresswire.com/ -- Substantial advancements and increased awareness …

Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025
How Parkinson’s affects million – and why current treatments are not enough Continuous dopaminergic stimulation (CDS): a next-gen approach to Parkinson’s care Serina’s drug candidate SER-252 is designed to deliver continuous symptom relief Join Serina CEO …

Nasal Spray Influenza Vaccine Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034
The Business Research Company's Nasal Spray Influenza Vaccine Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /EINPresswire.com/ -- The Business Research Company’s …

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of …

Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series
SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing next-generation CAR T-cell therapies for patients with cancer, announced today that members of its senior management …

Fitness App Market Is Booming Worldwide | Azumio, Appster, WillowTree
The Global Fitness App Market is projected to grow from $11.5 Billion in 2025 to $39.2 Billion by 2034, at a CAGR of 14.6%. HYDERABAD, TELANGANA, INDIA, June 23, 2025 /EINPresswire.com/ -- The latest study released on the Global Fitness App Market by …

Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to…
PALO ALTO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …

Jushi and Real Housewives Star Stacey Rusch Celebrate Successful Launch of Lifestyle Cannabis Brand ‘Shayo’
(Photo credit: Andreas Neumann) BOCA RATON, Fla., June 23, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF) has partnered with entrepreneur, philanthropist, and Real Housewives of Potomac star Stacey Rusch …

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for ROMVIMZA™ (vimseltinib)
LOUISVILLE, Ky., June 23, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a specialty pharmacy partner by Deciphera Pharmaceuticals, LLC for ROMVIMZA™ (vimseltinib), which has been approved by …

Cidara Announces Proposed Public Offering of Common Stock
SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced its plans to commence an …

Natural Alternatives International, Inc. Announces Amended and Extended Credit Facility with Wells Fargo Bank
CARLSBAD, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the execution of an amended credit …

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …

Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions
Phase 1 clinical study of TERN-601 demonstrated differentiated profile in 28-day study; topline data were presented in September 2024 Phase 2 FALCON clinical trial of TERN-601 completed enrollment; 12-week data expected in 4Q 2025 FOSTER CITY, Calif., June …

The Transdermal Drug Delivery Systems Market Report 2025 – Strategic Insights for Companies Seeking Growth & Advantage
The Business Research Company’s Transdermal Drug Delivery Systems Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /EINPresswire.com/ -- The Business Research Company’s …

Tuberous Sclerosis Drug Market Forecast to 2034 – For Business Leaders, Analysts, and Strategic Teams
The Business Research Company’s Tuberous Sclerosis Drug Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest …